Announcements Trials
Browse Landscape

Phase

Phase 2 48Phase NA 43Phase 1 28Phase 1/2 17Phase EARLY_PHASE1 11Phase 3 4Phase 2/3 1

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

NIH 7NETWORK 5OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Sarcoma 1Gynecologic 1

Conditions

Brain Neoplasms 2Recurrence 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Carcinosarcoma 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 166Gemcitabine 165Oxaliplatin 162Carboplatin 160Paclitaxel 152Leucovorin 122Drug Therapy 118Dexamethasone 118Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 56Neoadjuvant Therapy 53Lenalidomide 52Letrozole 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × X-Rays × Clear all
NCT05646316 2026-03-27

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

NRG Oncology

Phase 3 Recruiting
428 enrolled
Sarcoma

Carcinosarcoma

NCT04095364 2026-03-24

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NRG Oncology

Phase 3 Active not recruiting
450 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03750227 2025-12-24

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

Mayo Clinic

Phase 3 Recruiting
140 enrolled
CNS

Brain Neoplasms

NCT02636634 2016-04-11

CV-METANEC

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
90 enrolled
CNS

Brain Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡